iSpecimen (ISPC) Short-term Investments (2023 - 2024)
iSpecimen (ISPC) recorded quarterly Short-term Investments of $466493.0 in Q1 2024, down 82.48% quarter-over-quarter from $2.7 million in Q4 2023, and down 93.57% on a YoY basis from $7.3 million in Q2 2023.
iSpecimen (ISPC) Short-term Investments (2023 - 2024) Analysis & Trends
iSpecimen's Short-term Investments history runs 2 years deep, the most recent figure standing at $466493.0 for Q1 2024.
- In Q1 2024, Short-term Investments fell 93.57% year-over-year to $466493.0; the TTM figure through Mar 2024 stood at $466493.0 (down 93.57% YoY), while the FY2023 annual figure was $2.7 million, changed N/A from the prior year.
- Short-term Investments was $466493.0 for Q1 2024 at iSpecimen, down from $2.7 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $7.3 million in Q1 2023 to a low of $466493.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | iSpecimen | 1.02 Mn | -1.79 Mn | -1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 466,493.00 |
| Dec 31, 2023 | 2.66 Mn |
| Sep 30, 2023 | 2.94 Mn |
| Jun 30, 2023 | 6.21 Mn |
| Mar 31, 2023 | 7.26 Mn |